Complaisance of COVID-19 vaccination in cancer patients: A North Indian Tertiary Cancer Center (TCC) annotation

Arora Sehgal, Shailley; Malik, Garima; Atri, Rajeev; Kaur, Paramjeet; Malik, Rakesh; Sehgal, Sachin; Kaushal, Vivek; Chauhan, Ashok

doi:10.61186/rabms.9.4.200

Volume 9, Issue 4 (10-2023) Journal of Research in Applied and Basic Medical Sciences 2023, 9(4): 200-209 | Back to browse issues page

‎ 10.61186/rabms.9.4.200

Mendeley

Zotero

RefWorks

Arora Sehgal S, Malik G, Atri R, Kaur P, Malik R, Sehgal S, et al . Complaisance of COVID-19 vaccination in cancer patients: A North Indian Tertiary Cancer Center (TCC) annotation. Journal of Research in Applied and Basic Medical Sciences 2023; 9 (4) :200-209
URL: http://ijrabms.umsu.ac.ir/article-1-281-en.html

Complaisance of COVID-19 vaccination in cancer patients: A North Indian Tertiary Cancer Center (TCC) annotation

Shailley Arora Sehgal ^*

Assistant Professor, Department of Radiation Oncology, Regional Cancer Center, Pt B D Sharma PGIMS, Rohtak (Haryana), India , drshailley@gmail.com

Abstract: (1235 Views)

Background & Aims: Because of waxing and waning nature of Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), it has turned the entire globe upside down since its conception in December 2019. Vaccination against COVID-19 has emerged as the only ray of light in this dark tunnel of the pandemic, and has proven to curtail the morbidity and mortality associated with the viral infection. Thus, aspiration behind doing this study was to present the actual conformity of Indian cancer center patient population to COVID-19 vaccination.
Materials & Methods: The current prospective research was conducted on 396 cancer patients from North Indian Tertiary Cancer Center (TCC) between October 2021-February 2022 to analyze vaccine acceptance among its cancer patients. Face-to-face interviews were done to ask about the demographics and status of vaccination. Data was analyzed using SPSS v.25. Quantitative data presented as mean and standard deviation (SD). Qualitative data presented as ratios and percentages. Qualitative data were compared using Chi-square test. p<0.05 was considered significant.
Results: Among 396 patients, 221 (55.80%) were male and 175 (44.19%) were female, and mean age of study population was 55.96 years. 292 (73.74%) were from rural background while 104 (26.26%) belonged to urban background. Most common site of malignancy was head and neck cancer with 40.66% patients. 245 (61.36%) out of 396 patients were vaccinated either with single or both doses of COVID-19 vaccine, but 153 (38.64%) were not vaccinated. Out of vaccinated patients, 70.37% patients were fully vaccinated with 2 doses and 29.63% were vaccinated with single dose of COVID-19 vaccination.
Conclusion: Hesitancy of cancer patients in receiving COVID-19 vaccination is still a big hurdle to return to pre-pandemic oncological care, and this can be mitigated by amalgamated active efforts of government, treating oncologist and family of cancer patients.

Keywords: Cancer, COVID-19 Infection, COVID-19 Vaccine, Vaccine Acceptance

Full-Text [PDF 689 kb] (789 Downloads) | | Full-Text (HTML) (477 Views)

Type of Study: orginal article | Subject: Radiotherapy

References

1. WHO Coronavirus (COVID-19) Dashboard [Internet]. Geneva: World Health Organization; 2020 [2023 february 25]. Available from: https://covid19.who.int/. [URL]

2. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2021;71(3):209-49. [DOI:10.3322/caac.21660] [PMID]

3. Malik G, Sehgal SA, Dhull AK, Chauhan AK, Kaushal V. Preliminary Approach to Cancer Patient Care During Unprecedented COVID-19 Pandemic. Clin Infect Immun 2020;5(3):55-8. [DOI:10.14740/cii113]

4. Purohit N, Chugh Y, Bahuguna P, Prinja S. COVID-19 management: The vaccination drive in India. Health Policy Technol 2022;11(2):100636. [DOI:10.1016/j.hlpt.2022.100636] [PMID] []

5. Stefanile A, Cellerino M, Koudriavtseva T. Elevated risk of thrombotic manifestations of Sars-cov-2 infection in cancer patients: A literature review. EXCLI Journal 2022;21:906-920. [DOI:10.17179/excli2022-5073]

6. Saini KS, Tagliamento M, Lambertini M, McNally R, Romano M, Leone M, et al. Mortality in patients with cancer and coronavirus disease 2019: A systematic review and pooled analysis of 52 studies. Eur J Cancer 2020;139:43-50. [DOI:10.1016/j.ejca.2020.08.011] [PMID] []

7. Grivas P, Khaki AR, Wise-Draper TM, French B, Hennessy C, Hsu CY, et al. Association of clinical factors and recent anti-cancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium. Ann Oncol:32(6):787-800. [DOI:10.1016/j.annonc.2021.02.024] [PMID] []

8. Thirumalairaj R, Parikh PM, Agarwal A, Singh R, Krishnamurthy A, Desai SS, et al. South Asian Declaration-consensus guidelines for COVID-19 vaccination in cancer patients. South Asian J Cancer 2021;10(1):3-8. [DOI:10.1055/s-0041-1731909] [PMID] []

9. Garassino MC, Vyas M, De Vries EG, Kanesvaran R, Giuliani R, Peters S. The ESMO call to action on COVID-19 vaccinations and patients with cancer: Vaccinate. Monitor. Educate. Ann Oncol 2021;32(5):579-81. [DOI:10.1016/j.annonc.2021.01.068] [PMID] []

10. NCCN COVID-19 Vaccination guide for people with cancer. [Internet]. USA: National Comprehensive Cancer Network;2022 [2023 February 25]. https://www.nccn.org/docs/ default-source/covid-19/ covid-vaccine-and-cancer-05.pdf?sfvrsn=45cc3047_16. [URL]

11. Ministry of Health and Family Welfare India. Information Regarding COVID-19 Vaccine 2021 [Internet]. New Delhi: MOHFW Government of India; 2022 [2022 July]. https://main.mohfw.gov.in/newshighlights-31 [URL]

12. Gundavda MK, Gundavda KK. Cancer or COVID-19? A review of recommendations for COVID-19 vaccination in cancer patients. Curr Treat Options Oncol 2021;22(10):95. [DOI:10.1007/s11864-021-00903-7] [PMID] []

13. Polack FP, Thomas SJ, Kitchin N, Absalon J, Gurtman A, Lockhart S, et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med 2020;383(27):2603-15. [DOI:10.1056/NEJMoa2034577] [PMID] []

14. Baden LR, El Sahly HM, Essink B, Kotloff K, Frey S, Novak R, et al. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. N Engl J Med 2021;384(5):403-16. [DOI:10.1056/NEJMoa2035389] [PMID] []

15. Sadoff J, Gray G, Vandebosch A, Cárdenas V, Shukarev G, Grinsztejn B, et al. Safety and efficacy of single-dose Ad26.COV2.S vaccine against Covid-19. N Eng J Med 2021;384(23):2187-201. https://doi.org/10.1056/NEJMoa2101544 [DOI:10.1056/nejmoa2101544] [PMID] []

16. Thomas SJ, Perez JL, Lockhart SP, Hariharan S, Kitchin N, Bailey R, et al. Efficacy and safety of the BNT162b2 mRNA COVID-19 vaccine in participants with a history of cancer: subgroup analysis of a global phase 3 randomized clinical trial. Vaccine 2022;40(10):1483-92. [DOI:10.1016/j.vaccine.2021.12.046] [PMID] []

17. Wang Q, Berger NA, Xu R. When hematologic malignancies meet COVID-19 in the United States: infections, death and disparities. Blood Rev 2020;47:100775. [DOI:10.1016/j.blre.2020.100775] [PMID] []

18. Wang Q, Berger NA, Xu R. Analyses of risk, racial disparity, and outcomes among US patients with cancer and COVID-19 infection. JAMA Oncol 2021;7(2):220-7. [DOI:10.1001/jamaoncol.2020.6178] [PMID] []

19. Heudel P, Favier B, Assaad S, Zrounba P, Blay JY. Reduced SARS-CoV-2 infection and death after two doses of COVID-19 vaccines in a series of 1503 cancer patients. Ann Oncol 2021;32(11):1443-4. [DOI:10.1016/j.annonc.2021.07.012] [PMID] []

20. Ministry of Health and Family Welfare. India's COVID-19 cumulative vaccine coverage. [Internet]. Delhi: Press Information Bureau; 2022 [2022 August]. https://pib.gov.in/PressReleaseIframePage.aspx?PRID=1846658. [URL]

21. Batra U, Nathany S, Bansal N, Sharma M. COVID-19 vaccination status in Indian patients with cancer: An observational study. Cancer Res Stat Treat 2021;4(2):219-23. [DOI:10.4103/crst.crst_131_21]

22. Institute of Health Metrics and Evaluation. COVID-19 Results Briefing India [Internet]. India:IHME;2022 [2022 June]. https://www.healthdata.org/sites/default/files/files/163_briefing_India_4.pdf. [URL]

23. UNICEF. Building confidence in the COVID-19 vaccine in India [Internet]. New Delhi: UNICEF India; 2021 [2022 July 15]. [DOI:10.31899/pgy15.1065]

24. Lazarus JV, Wyka K, White TM, Picchio CA, Gostin LO, Larson HJ, et al. A survey of COVID-19 vaccine acceptance across 23 countries in 2022. Nat Med 2023;29(2):366-75. [DOI:10.1038/s41591-022-02185-4] [PMID]

25. Kelkar AH, Blake JA, Cherabuddi K, Cornett H, McKee BL, Cogle CR. Vaccine enthusiasm and hesitancy in Cancer patients and the impact of a webinar. Healthcare 2021;9(3):351. [DOI:10.3390/healthcare9030351] [PMID] []

26. Mejri N, Berrazega Y, Ouertani E, Rachdi H, Bohli M, Kochbati L, et al. Understanding COVID-19 vaccine hesitancy and resistance: another challenge in cancer patients. Support Care Cancer 2022;30(1):289-93. [DOI:10.1007/s00520-021-06419-y] [PMID] []

27. Barrière J, Gal J, Hoch B, Cassuto O, Laysalle A, Chamorey E, et al. Acceptance of SARS-CoV-2 vaccination among French patients with cancer: a cross-sectional survey. Ann Oncol 2021;32(5):673-4. [DOI:10.1016/j.annonc.2021.01.066] [PMID] []

28. Dhalaria P, Arora H, Singh AK, Mathur M, S AK. COVID-19 vaccine hesitancy and vaccination coverage in India: An exploratory analysis. Vaccines 2022;10(5):739. [DOI:10.3390/vaccines10050739] [PMID] []

29. Brodziak A, Sigorski D, Osmola M, Wilk M, Gawlik-Urban A, Kiszka J, et al. Attitudes of patients with cancer towards vaccinations-results of online survey with special focus on the vaccination against COVID-19. Vaccines 2021;9(5):411. [DOI:10.3390/vaccines9050411] [PMID] []

30. Mandal A, Singh P, Samaddar A, Singh D, Verma M, Rakesh A, et al. Vaccination of cancer patients against COVID-19: towards the end of a dilemma. Med Oncol 2021;38(8):92. [DOI:10.1007/s12032-021-01540-8] [PMID] []